Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy

See also Lowe GDO. Arterial disease and venous thrombosis: are they related, and if so, what should we do about it? This issue, pp 1882-5; Agnelli G, Becattini C. Venous thromboembolism and atherosclerosis: common denominators or different diseases? This issue, pp 1886-90; Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, Sorensen H, Pesavento R, Iotti M, Casiglia E, Iliceto S, Pagnan A, Lensing AWA. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. This issue, pp 1891-6; Eliasson angstrom, Bergqvist D, Bjorck M, Acosta S, Sternby NH, Ogren M. Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies. This issue, pp 1897-1902; van der Hagen PB, Folsom AR, Jenny NS, Heckbert SR, O'Meara ES, Reich LM, Rosendaal FR, Cushman M. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. This issue, pp 1903-8; Reich LM, Folsom AR, Key NS, Boland LL, Heckbert SR, Rosamond WD, Cushman M. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. This issue, pp 1909-13; Ageno W, Prandoni P, Romualdi E, Ghirarduzzi A, Dentali F, Pesavento R, Crowther M and Venco A. The metabolic syndrome and the risk of venous thrombosis: a case-control study. This issue, pp 1914-8; S Young L, Ockelford P, Milne D, Rolfe-Vyson V, McKelvie S, Harper P. Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. This issue, pp 1919-24; Squizzato A, Romualdi E, Ageno W. Why should statins prevent venous thromboembolism? A systematic literature search and a call for action. This issue, pp 1925-7.